Table 4.
NKG2D Hb-1 haplotype frequency in healthy controls and melanoma patients.
| NKG2D Hb-1 Haplotypes |
Controls | Melanoma Patients | ||
|---|---|---|---|---|
| Total | p/Pc | (X2) | ||
| NK-1 | 0.587 | 0.619 | 0.33 | (0.94) |
| NK-2 | 0.329 | 0.276 | 0.09 | (2.87) |
| NK-3 | 0.015 1 | 0.048 | 0.007/0.098 | (7.26) |
| NK-4 | 0.010 | 0.011 | 0.93 | (0.008) |
| NK-5 | 0.010 | 0.011 | 0.92 | (0.009) |
| NK-6 | 0.010 | 0.009 | 0.82 | (0.052) |
| NK-7 | 0.005 | 0.013 | 0.23 | (1.45) |
| NK-8 | 0.005 | 0.007 | 0.74 | (0.11) |
| NK-9 | 0.005 | 0.006 | 0.84 | (0.04) |
| NK-10 | 0.010 2 | 0.000 | 0.03/0.42 | (4.56) |
| NK-11 | 0.005 | 0.000 | 0.14 | (2.19) |
| NK-12 | 0.003 | 0.000 | 0.27 | (1.19) |
| NK-13 | 0.003 | 0.000 | 0.31 | (1.04) |
| NK-14 | 0.003 | 0.000 | 0.27 | (1.21) |
Healthy controls and melanoma patients (n = 400 and 466 chromosomes respectively). 1 p/Pc = 0.007/0.098 and X2 = 7.26; 2 p/Pc = 0.03/0.42 and X2 = 4.56. p-value was determined by Chi-square test.